{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:35:24Z","timestamp":1789972524170,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["2014\/13\/B\/NZ7\/02222"],"award-info":[{"award-number":["2014\/13\/B\/NZ7\/02222"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004382","name":"Polish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pnpbp.2017.06.022","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T07:32:45Z","timestamp":1498116765000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"PB","title":["The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test"],"prefix":"10.1016","volume":"79","author":[{"given":"Agnieszka","family":"Pa\u0142ucha-Poniewiera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Podkowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Pilc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.06.022_bb0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0361-9230(88)90151-7","article-title":"Effects of locally infused pharmacological agents on spontaneous and sensory-evoked activity of locus coeruleus neurons","volume":"21","author":"Adams","year":"1988","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-4328(97)02298-5","article-title":"The effect of nonspatial water maze pretraining in rats subjected to serotonin depletion and muscarinic receptor antagonism: a detailed behavioural assessment of spatial performance","volume":"88","author":"Beiko","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0091-3057(01)00448-8","article-title":"Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats","volume":"68","author":"Bertrand","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(97)80988-6","article-title":"Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist","volume":"82","author":"Carli","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/mp.2016.34","article-title":"Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects","volume":"22","author":"Chowdhury","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system. A relationship to aging?","volume":"30","author":"Drachman","year":"1974","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0040","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopsych.2012.09.031","article-title":"Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review","volume":"73","author":"Drevets","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0006-8993(99)01669-8","article-title":"Serotonin-dependent maintenance of spatial performance and electroencephalography activation after cholinergic blockade: effects of serotonergic receptor antagonists","volume":"837","author":"Dringenberg","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial","volume":"63","author":"Furey","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2044.1962.tb13473.x","article-title":"The amnesic properties of hyoscine and atropine in pre-anaesthetic medication","volume":"17","author":"Hardy","year":"1962","journal-title":"Anaesthesia"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pnpbp.2016.05.007","article-title":"Potential involvement of serotonergic signaling in ketamine's antidepressant actions: a critical review","volume":"71","author":"du Jardin","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0065","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2015.06.012","article-title":"Rapid antidepressant actions of scopolamine: role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors","volume":"82","author":"Navarria","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00213-007-0728-9","article-title":"Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test","volume":"192","author":"O'Leary","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.euroneuro.2006.06.012","article-title":"The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs","volume":"17","author":"O'Leary","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0080","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1124\/jpet.110.169730","article-title":"The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent","volume":"334","author":"Pa\u0142ucha-Poniewiera","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-013-3206-6","article-title":"The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent","volume":"231","author":"Pa\u0142ucha-Poniewiera","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2016.08.031","article-title":"Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495","volume":"111","author":"Podkowa","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12868-016-0300-9","article-title":"Neuroprotective effects of HTR1A antagonist WAY-100635 on scopolamine-induced delirium in rats and underlying molecular mechanisms","volume":"17","author":"Qiu","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543784.6.1.65","article-title":"Venlafaxine: a novel antidepressant compound","volume":"6","author":"Schweizer","year":"1997","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/0253-7613.161260","article-title":"Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice","volume":"47","author":"Singh","year":"2015","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0120","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1185\/03007990802472700","article-title":"Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures","volume":"24","author":"Tytgat","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0125","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.biopsych.2013.04.025","article-title":"Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses","volume":"74","author":"Voleti","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/jpet.114.216804","article-title":"M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine","volume":"351","author":"Witkin","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2017.06.022_bb0135","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1172\/JCI85033","article-title":"GABA interneurons mediate the rapid antidepressant-like effects of scopolamine","volume":"126","author":"Wohleb","year":"2016","journal-title":"J. Clin. Invest."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617302208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617302208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T07:36:13Z","timestamp":1656315373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584617302208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":27,"alternative-id":["S0278584617302208"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.022","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}